Advertisement
News
Subscribe to MDT Magazine News

RF Technologies® Announces Distributor Agreement With Universal Hospital Services

January 11, 2011 7:36 am | by Bio-Medicine.Org | Comments

BROOKFIELD, Wis., Jan. 11, 2011 /- RF Technologies®, a leading provider of radio frequency identification monitoring systems and healthcare security solutions, has announced a distributor agreement with Universal Hospital Services, Inc. ("UHS"), a leading provider of medical...

TOPICS:

Dan Rather Reports Investigates our Heavy Dependence on Antibiotics - What are the Causes... and the Consequences?

January 11, 2011 7:36 am | by Bio-Medicine.Org | Comments

DALLAS, Jan. 11, 2011 /- Tonight's "Dan Rather Reports" examines the alarming health consequences resulting from the overuse of antibiotics. Every year, more than 90,000 Americans die from "superbugs" that antibiotics cannot treat; these antibiotic-resistant infections, caused directly by...

TOPICS:

BioMarin Initiates Phase 1/2 Trial for BMN 673 for the Treatment of Genetically-Defined Cancers

January 11, 2011 7:35 am | by Bio-Medicine.Org | Comments

NOVATO, Calif., Jan. 11, 2011 /- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN ) today announced the initiation of a Phase 1/2 trial for BMN 673, a poly ADP-ribose polymerase (PARP) inhibitor in development for the treatment of genetically-defined cancers.   "PARP inihibtors have been...

TOPICS:
Advertisement

Life Technologies approves $500M stock buyback

January 11, 2011 6:45 am | by The Associated Press | Comments

Life Technologies Corp., a life sciences and medical research tools company, said Tuesday it will buy back up to $500 million common shares.The company has about 186.7 million shares of common stock outstanding.Shares of Life Technologies rose 24 cents to $56.19 in morning trading.

Virtual Radiologic Ranked #1 for Teleradiology Services for Third Consecutive Year

January 11, 2011 6:35 am | by Bio-Medicine.Org | Comments

EDEN PRAIRIE, Minn., Jan. 11, 2011 /- Virtual Radiologic (vRad), a technology-enabled national radiology practice, has again been ranked "Best in KLAS" in the Teleradiology Services market segment by independent research and consulting firm KLAS. This ranking measures performance based...

TOPICS:

Reportlinker Adds Germany Pharmaceutical Market Overview - New pricing rules set to negatively impact drug sales both domestically and internationally

January 11, 2011 6:34 am | by Bio-Medicine.Org | Comments

NEW YORK, Jan. 11, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Germany Pharmaceutical Market Overview – New pricing rules set to negatively impact drug sales both domestically and internationally...

TOPICS:

Nfocus Neuromedical Announces FDA 510(k) Clearance for Next Generation Device to Treat Vascular Lesions

January 11, 2011 6:34 am | by Bio-Medicine.Org | Comments

PALO ALTO, Calif., Jan. 11, 2011 /- Nfocus Neuromedical, Inc., an innovative medical device company with a focus on the next generation treatment for brain aneurysms, today announced that the company received U.S. Food and Drug Administration 510(k) clearance for its Acta™ Vessel...

TOPICS:

Dehaier Medical Announces Participation in Arab Health 2011

January 11, 2011 6:33 am | by Bio-Medicine.Org | Comments

BEIJING, Jan. 11, 2011 /PRNewswire-Asia-FirstCall/ -- Dehaier Medical Systems Ltd. (Nasdaq: DHRM ) ("Dehaier" or the "Company"), an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products in China, today announced that it will...

TOPICS:
Advertisement

Idex buying equipment maker Microfluidics

January 11, 2011 5:45 am | by The Associated Press | Comments

Idex Corp. said Tuesday it will acquire Microfluidics International Corp., which makes equipment that laboratories and commercial companies use to make materials for the drug and chemical markets.Idex said its offer values Microfluidics at $1.35 per share, a 69 percent premium above its...

CareFusion Announces Sale of OnSite Services Instrument Management and Repair Business

January 11, 2011 5:35 am | by Bio-Medicine.Org | Comments

SAN DIEGO, Jan. 11, 2011 /- CareFusion (NYSE: CFN ), a leading, global medical device company, today announced that it has signed an agreement to sell its OnSite Services instrument management and repair business to Frazier Healthcare. Financial terms of the agreement were not disclosed....

TOPICS:

First Five-Year Outcomes Published on CyberKnife Radiosurgery for Prostate Cancer

January 11, 2011 5:35 am | by Bio-Medicine.Org | Comments

SUNNYVALE, Calif., Jan. 11, 2011 /- Accuray Incorporated (Nasdaq: ARAY ), a global leader in the field of radiosurgery, announced today the first published five-year outcomes on low risk prostate cancer patients treated with the CyberKnife® Robotic Radiosurgery System . The...

TOPICS:

Reportlinker Adds France Pharmaceutical Market Overview - Austerity measures will impact pharmaceutical market growth

January 11, 2011 5:34 am | by Bio-Medicine.Org | Comments

NEW YORK, Jan. 11, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: France Pharmaceutical Market Overview – Austerity measures will impact pharmaceutical market growth...

TOPICS:

Siemens Launches PEP, a Personalized Education Plan for Clinical Laboratory and Healthcare Professionals

January 11, 2011 5:33 am | by Bio-Medicine.Org | Comments

DEERFIELD, Ill., Jan. 11, 2011 /- Siemens Healthcare Diagnostics introduces Personalized Education Plan (PEP): the industry's first competency-based clinical laboratory education model focused exclusively on the individual. Healthcare professionals, guided by their own instructional...

TOPICS:

STAAR Surgical forecasts 4Q revenue outlook

January 11, 2011 4:45 am | by The Associated Press | Comments

Implantable eye lens maker STAAR Surgical Co. said Tuesday it expects about $14.2 million in revenue in the fourth quarter, a decrease of 28 percent from the fourth quarter of 2009.STAAR said revenue from its implantable collamer lens products grew 13 percent in the quarter and surgery volumes...

Rib-X raises $20M to develop antibiotics

January 11, 2011 4:36 am | by Mass High Tech: The Journal of New England Technology | Comments

Rib-X Pharmaceuticals Inc., an antibiotics company in New Haven, Conn., has taken in a $20 million financing, led by Warburg Pincus LLC.

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading